- A prospective randomized trial indicated that treatment of androgenic alopecia (AGA) with platelet-rich plasma (PRP) products is safe and effective among both men and women
Why this matters
- Previous clinical studies have pointed to the safety and effectiveness of PRP in the treatment of AGA.
- At 6 months, both patient groups studied had a statistically significant increase in hair count (P<.001 and a higher more rapid response was seen in group>
- Patients in group 1 received 3 subdermal PRP injections per month and a booster dose after 3 months.
- Patients in group 2 received 2 subdermal PRP injections every 3 months.
- Folliscope hair count increased significantly (29.6±13.6 in group 1 vs 7.2±10.4 in group 2; P<.001 in both groups.>
- Shaft caliber increased significantly in both groups with no significant difference between groups.
- Survey results showed patients had high satisfaction with treatment (82% of patients were satisfied or highly satisfied).
- Treatment was well-tolerated, with a mean pain score of 2.1.
- 40 patients with moderate AGA were analyzed in a prospective randomized single-blinded trial.
- Patients were randomly assigned according to 2 treatment protocols (group 1 received 3 injections per month followed by a booster dose at 3 months, and group 2 received 2 injections every 3 months).
- Funding: Eclipse Aesthetics, LLC.
- Small number of patients.